Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 9Phase 3 3Phase 1/2 3Phase NA 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 20INDUSTRY 8NETWORK 7NIH 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 93Breast 86Other hematologic neoplasm 63Lymphoid 63Genitourinary 56Thoracic 54Gynecologic 35CNS 28Sarcoma 26Plasma cell 25Dermatologic 25Head & Neck 21Myeloid 17Classical hematology 13Other solid neoplasm 4Other 4Other neoplasm 3Endocrine 3Tumor-Agnostic 2NET 2

Conditions

Precancerous Conditions 3Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Keratosis, Actinic 1

Interventions

Vaginal Smears 1Sulindac 1Polymerase Chain Reaction 1Eflornithine 1Deoxyribonuclease (Pyrimidine Dimer) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × NIH × Other neoplasm × Clear all
NCT00118365 2015-01-22

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

National Cancer Institute (NCI)

Phase 3 Completed
375 enrolled 27 charts
Other neoplasm

Precancerous Conditions

NCT00002811 2013-11-06

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

National Cancer Institute (NCI)

Phase 3 Unknown
30 enrolled
DermatologicOther neoplasm

Precancerous Conditions, Keratosis, Actinic

NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡